Gene · 8647
Papers3,310
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,310
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Revisited role of the placenta in bile acid homeostasis. | Front Physiol | 2023 | 37546542 | PubTator, text mining | PubMed |
| Apical bulkheads accumulate as adaptive response to impaired bile flow in liver disease. | EMBO Rep | 2023 | 37522754 | PubTator, text mining | PubMed |
| Progressive Familial Intrahepatic Cholestasis: A Descriptive Study in a Tertiary Care Center. | Int J Hepatol | 2023 | 37520499 | PubTator, text mining | PubMed |
| ABCB11 accumulated in immature tertiary lymphoid structures participates in xenobiotic metabolic process and predicts resistance to PD-1/PD-L1 inhibitors in head and neck squamous cell carcinoma. | Transl Oncol | 2023 | 37517143 | PubTator, text mining | PubMed |
| The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease. | Intern Emerg Med | 2023 | 37515676 | PubTator, text mining | PubMed |
| Upregulation of Taurine Biosynthesis and Bile Acid Conjugation with Taurine through FXR in a Mouse Model with Human-like Bile Acid Composition. | Metabolites | 2023 | 37512531 | PubTator, text mining | PubMed |
| MicroRNAs as a Potential Biomarker in the Diagnosis of Cardiovascular Diseases. | Medicina (Kaunas) | 2023 | 37512140 | PubTator, text mining | PubMed |
| Influence of the Bile Acid Transporter Genes ABCB4, ABCB8, and ABCB11 and the Farnesoid X Receptor on the Response to Ursodeoxycholic Acid in Patients with Nonalcoholic Steatohepatitis. | J Pers Med | 2023 | 37511794 | PubTator, text mining | PubMed |
| Current Data and New Insights into the Genetic Factors of Atherogenic Dyslipidemia Associated with Metabolic Syndrome. | Diagnostics (Basel) | 2023 | 37510094 | PubTator, text mining | PubMed |
| Quantitative Systems Toxicology Identifies Independent Mechanisms for Hepatotoxicity and Bilirubin Elevations Due to AKR1C3 Inhibitor BAY1128688. | Clin Pharmacol Ther | 2023 | 37501650 | PubTator, text mining | PubMed |
| Loss of Mtm1 causes cholestatic liver disease in a model of X-linked myotubular myopathy. | J Clin Invest | 2023 | 37490339 | PubTator, text mining | PubMed |
| Analysis of various ATP-binding cassette transporters revealed quantification of ABCB4 as a potential diagnostic tool in primary sclerosing cholangitis (PSC). | Histopathology | 2023 | 37488782 | PubTator, text mining | PubMed |
| A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report. | BMC Med Genomics | 2023 | 37488596 | PubTator, text mining | PubMed |
| Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease. | PLoS One | 2023 | 37471416 | PubTator, text mining | PubMed |
| A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs. | Nat Commun | 2023 | 37468498 | PubTator, text mining | PubMed |
| Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum. | Acta Neuropathol | 2023 | 37466726 | PubTator, text mining | PubMed |
| Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products. | Front Immunol | 2023 | 37457696 | PubTator, text mining | PubMed |
| Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives. | Pharmgenomics Pers Med | 2023 | 37457231 | PubTator, text mining | PubMed |
| Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis. | JHEP Rep | 2023 | 37456676 | PubTator, text mining | PubMed |
| A novel 6-day cycle surgical pathology rotation improves resident satisfaction and maintains Accreditation Council for Graduate Medical Education (ACGME) milestone performance. | Acad Pathol | 2023 | 37448760 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8647/papers?page=16